Is Affirm Stock an Undervalued Stock to Buy? | AFRM STock Analysis

AI-generated source summary

Affirm's consumer health remains strong, with no observed change in demand or ability to repay. Delinquencies are in line with expectations, driven partly by a reduced tax refund seasonality. Strong unit economics are noted, with the company capturing demand that delivered great returns. Credit continues to be a focus. Zesty capital markets demand reflects confidence in their approach to credit. The company increased capacity despite lower seasonal volume, and priced its third consecutive revolving ABS transaction at a favorable yield. Average annualized cost of funds reached a three-and-a-half-year low. The company has seen significant growth in active consumers and active merchants, increasing by 44% to 515,000. Active consumers grew 22% to 26.8 million. The valuation appears attractive, with a forward price-to-earnings ratio of 16.34 and a forward price-to-free cash flow ratio of 12.25, suggesting a potentially undervalued stock for investors with a higher risk tolerance.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   18 May 2026, 14:45 UTC

   The analyst published the original source item.

2. Source recorded by Tahlil Plus

   19 May 2026, 02:24 UTC

   The public source was preserved as the evidence record for this case.

3. Market predictions extracted

   19 May 2026, 03:07 UTC

   1 eligible signal linked to this case.

4. Source processing completed

   19 May 2026, 03:07 UTC

   Source analysis and structured extraction completed.

5. Outcome tracking started

   20 May 2026, 01:02 UTC

   Tahlil Plus began monitoring the extracted predictions.

6. Live evaluation in progress

   01 Aug 2026, 02:07 UTC

   1 signal remains active.